Laboratories Abbott insider trades: Mylan (MYL) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Laboratories reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 23, 2017 | MYL | ↓ Sell | 44,000,000 | $41.60 | $1.83B | By Subsidiaries | Mar 24, 2017 (1d) |
| Apr 20, 2010 | FACT | ↑ Buy | 62,652,055 | $27.00 | $1.69B | Direct | Apr 21, 2010 (1d) |
| Feb 26, 2009 | EYE | ↑ Buy | 44,720,768 | $22.00 | $983.9M | By wholly owned subsidiary | Feb 27, 2009 (1d) |
| Feb 25, 2009 | EYE | ↑ Buy | 56,395,914 | $22.00 | $1.24B | By wholly owned subsidiary | Feb 25, 2009 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Laboratories Abbott's insider trades
Laboratories Abbott is a 10% owner of Mylan (MYL). Since Feb 25, 2009, Laboratories has reported 3 open-market purchases worth $3.92B and 1 sale worth $1.83B on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include other transactions (4 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MYL insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.